A detailed history of Madison Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Madison Asset Management, LLC holds 21,932 shares of ABBV stock, worth $3.67 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
21,932
Previous 15,217 44.13%
Holding current value
$3.67 Million
Previous $2.36 Million 69.34%
% of portfolio
0.05%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $1.07 Million - $1.22 Million
6,715 Added 44.13%
21,932 $3.99 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $842,112 - $948,416
6,120 Added 67.27%
15,217 $2.36 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $1.22 Million - $1.41 Million
9,097 New
9,097 $1.36 Million
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $24,342 - $29,193
-176 Reduced 5.71%
2,906 $470,000
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $10,334 - $11,852
-77 Reduced 2.44%
3,082 $414,000
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $35,643 - $45,314
-259 Reduced 7.58%
3,159 $484,000
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $34,974 - $43,393
-265 Reduced 7.2%
3,418 $554,000
Q4 2021

Feb 15, 2022

SELL
$107.43 - $135.93 $750,720 - $949,878
-6,988 Reduced 65.49%
3,683 $499,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $89,056 - $101,092
837 Added 8.51%
10,671 $1.15 Million
Q2 2021

Aug 09, 2021

BUY
$105.21 - $117.21 $76,382 - $85,094
726 Added 7.97%
9,834 $1.11 Million
Q1 2021

May 11, 2021

SELL
$102.3 - $112.62 $50,843 - $55,972
-497 Reduced 5.17%
9,108 $986,000
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $407,570 - $545,389
5,555 Added 137.16%
9,605 $943,000
Q1 2020

May 12, 2020

BUY
$64.5 - $97.79 $261,225 - $396,049
4,050 New
4,050 $309,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Madison Asset Management, LLC Portfolio

Follow Madison Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Madison Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Madison Asset Management, LLC with notifications on news.